News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Day In Review: Biotech Consolidates After Recent Gains



10/19/2005 5:12:38 PM

February 7, 2005 -- Two weeks ago, the market hit its lowest point of the year by sliding 2.7% or 89 points to 3230. Since then, the Centient Biotech 200 has rallied an impressive 7.4% or 240 points and that is including today’s fairly minor loss. In today’s trading, the final figures on the CBT 200 show a loss of 12.08 points (.35%) to 3470.34. In individual stocks, Allergan guided lower and the stock followed suit, Axonyx took a clobbering after its Alzheimer's drug failed a Phase III trial, InterMune lost ground after guiding lower, Vicuron moved up on news of a positive trial for its fungal infection drug, and Biosite leased 50 diagnostic targets from Incyte. We give more details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES